Skip to content

Source filing unavailable

Q1 2011 · —
Revenue$10.24M+15.8% vs Q1 2010−39.0% vs Q4 2010
Net Income-$18.40MN/M vs Q1 2010N/M vs Q4 2010
EPS Diluted-$0.19N/M vs Q1 2010N/M vs Q4 2010
Operating Income-$18,542,000—
Operating Cash Flow-$23,913,000—
Free Cash Flowderived-$27,381,000—
Margins · derived
Operating margin-181.1%
Net margin-179.7%+4.1 pt vs Q1 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2011Q1 2010
Revenue$10.24M$8.84M
Net Income-$18.40M-$16.25M
EPS Diluted-$0.19-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR